Dupixent

List of products in the National Drug Code with proprietary name dupixent. This medication is used to treat a skin condition called eczema (atopic dermatitis). It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0024-5911Dupixent DupilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5914Dupixent DupilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5915Dupixent DupilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5918Dupixent DupilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5919Dupixent DupilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug